EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Price, Quote, News and Overview
FRA:EWL - Deutsche Boerse Ag - US28176E1082 - Common Stock - Currency: EUR
EWL.DE Quote, Performance and Key Statistics
EDWARDS LIFESCIENCES CORP
FRA:EWL (1/22/2025, 7:00:00 PM)
66.86
-0.24 (-0.36%)
The current stock price of EWL.DE is 66.86 EUR. In the past month the price decreased by -4.01%. In the past year, price decreased by -0.86%.
EWL.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| IUI1.DE | INTUITIVE SURGICAL INC | 91.65 | 209.90B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 89.78 | 205.62B | ||
| ABL.DE | ABBOTT LABORATORIES | 26.41 | 198.32B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 43.14 | 143.70B | ||
| 2M6.DE | MEDTRONIC PLC | 16.84 | 108.61B | ||
| 1MDT.MI | MEDTRONIC PLC | 16.67 | 107.51B | ||
| BOX.DE | BECTON DICKINSON AND CO | 18.21 | 66.56B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 24.37 | 61.30B | ||
| DC4.DE | DEXCOM INC | 51.69 | 32.91B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 19.86 | 24.08B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 19.77 | 23.97B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 19.42 | 23.55B |
Related screens
About EWL.DE
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 19,800 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). The company develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.
Company Info
EDWARDS LIFESCIENCES CORP
One Edwards Way
Irvine CALIFORNIA US
Employees: 19800
Company Website: https://www.edwards.com
Investor Relations: https://ir.edwards.com/
Phone: 19492502500
EWL.DE FAQ
What is the price of EWL.DE?
The current price of EWL.DE is 66.86 EUR.
What is the symbol for EDWARDS LIFESCIENCES CORP?
The exchange symbol of EDWARDS LIFESCIENCES CORP is EWL and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is EWL.DE listed?
EWL.DE is listed on the Deutsche Boerse Ag exchange.
Is EWL.DE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for EWL.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of EWL.DE.
Does EWL.DE pay dividends?
EWL.DE does not pay a dividend.
When does EWL.DE report earnings?
EWL.DE will report earnings on 2025-01-30, after the market close.
What is the Price/Earnings (PE) ratio of EWL.DE?
The PE ratio for EWL.DE is 26.12. This is based on the reported non-GAAP earnings per share of 2.56 and the current share price of 66.86 EUR.
EWL.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to EWL.DE. When comparing the yearly performance of all stocks, EWL.DE is a bad performer in the overall market: 64.63% of all stocks are doing better.
EWL.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE. EWL.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
EWL.DE Financial Highlights
Over the last trailing twelve months EWL.DE reported a non-GAAP Earnings per Share(EPS) of 2.56. The EPS decreased by 6.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 73.98% | ||
| ROA | 32.06% | ||
| ROE | 43.57% | ||
| Debt/Equity | 0.06 |
EWL.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to EWL.DE. The Buy consensus is the average rating of analysts ratings from 42 analysts.
For the next year, analysts expect an EPS growth of 3.46% and a revenue growth -3.3% for EWL.DE